Search

Your search keyword '"Tosetto A"' showing total 2,175 results

Search Constraints

Start Over You searched for: Author "Tosetto A" Remove constraint Author: "Tosetto A"
2,175 results on '"Tosetto A"'

Search Results

2. A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group

3. Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy

4. A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report

5. Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

6. More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

7. The experience of pregnant women and their families who were infected with covid-19 before vaccination: A qualitative approach within a multicenter study in Brazil

11. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)

12. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

15. A fish can change its stripes: investigating the role of body colour and pattern in the bluelined goatfish

16. Stains

20. Association of sex with major bleeding risks in sub-Saharian anticoagulated patients with mechanical heart valves: A cohort study from the Khartoum Emergency Salam Centre.

21. Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry

22. Butyrate limits human natural killer cell effector function

23. Pentafecta outcomes of robotic laparoscopically assisted radical prostatectomy during the initial experience in a university hospital

26. Dynamic colour change as a signalling tool in bluelined goatfish (Upeneicthtys lineatus)

27. P1183: CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS AND AT RELAPSE IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF THE 'RETE EMATOLOGICA VENETA' (T-REV PROJECT).

30. Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes

31. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

32. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment

33. Planktonic cnidarian responses to contrasting thermohaline and circulation seasonal scenarios in a tropical western boundary current system

34. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

36. MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY

37. A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report

39. Notulae to the Italian alien vascular flora: 13

40. Amazon River plume habitats shape planktonic cnidarian assemblages in the Western Atlantic.

41. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

42. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study

45. The Amazon River plume, a barrier to animal dispersal in the Western Tropical Atlantic

47. Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature

48. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

49. Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.

50. Real‐world experience of rIX‐FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy – Results from IDEAL Part B.

Catalog

Books, media, physical & digital resources